Weiwei. An, et.al., Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production., PloS one, 2015, 10

http://rdf.ncbi.nlm.nih.gov/pubmed/26161966

Weiwei. An, et.al., Cyclin Y Is Involved in the Regulation of Adipogenesis and Lipid Production., PloS one, 2015, 10

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5688373

class

http://purl.org/net/cito/citesAsAuthority

• Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5688373

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating free fatty acid level_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0002702IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased body weight_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0001262IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased total body fat amount_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0010025IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• increased lean body mass_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0003960IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• abnormal fat pad morphology_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0005334IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• abnormal brown adipose tissue physiology_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0011698IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased liver triglyceride level_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0009356IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• abnormal fat cell differentiation_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0011168IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased renal fat pad weight_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0009303IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• increased respiratory quotient_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0010378IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased circulating triglyceride level_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0002644IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased retroperitoneal fat pad weight_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0009305IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased inguinal fat pad weight_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0009293IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• increased energy expenditure_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0004889IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• increased oxygen consumption_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0005289IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• hyperactivity_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0001399IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased white fat cell size_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0009133IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• increased carbon dioxide production_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0008963IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo
• decreased circulating cholesterol level_Ccny<tm1.1Srcmo>/Ccny<tm1.1Srcmo>
  http://metadb.riken.jp/0005179IC57BL6Ccnytm11SrcmoCcnytm11SrcmoCcnytm11Srcmo